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Abstract
Background: To investigate the association between fasting serum insulin and glucose levels with atherosclerotic 
plaque composition in the carotid artery. Impaired insulin and glucose levels are implicated in the etiology of 
cardiovascular disease; however, their influence on the formation and composition of atherosclerotic plaque remains 
unclear.
Methods: In 1740 participants (mean age 72.9 years, 46% women, 14.4% diabetes mellitus) from the population-based 
Rotterdam Study, we performed carotid MRI to evaluate the presence of calcification, lipid core, and intraplaque 
hemorrhage in carotid atherosclerosis. All participants also underwent blood sampling to obtain information on 
serum insulin and glucose levels. Using logistic regression models, we assessed the association of serum insulin and 
glucose levels (per s.d. and in tertiles) with the different plaque components, while adjusting for sex, age, intima-media 
thickness, and cardiovascular risk factors.
Results: Serum insulin levels were associated with the presence of intraplaque hemorrhage (adjusted odds ratio (OR): 
1.42 (95% CI: 1.12–1.7)) We found no association with the presence of calcification or lipid core. Sensitivity analyses 
restricted to individuals without diabetes mellitus yielded similar results. No associations were found between serum 
glucose levels and any of the plaque components.
Conclusions: Serum insulin levels are associated with the presence of vulnerable components of carotid plaque, 
specifically with intraplaque hemorrhage. These findings suggest a complex role for serum insulin in the 
pathophysiology of carotid atherosclerosis and in plaque vulnerability.
Introduction
Dysregulations in insulin and glucose metabolism, the 
pathophysiological underpinnings of diabetes mellitus, 
are associated with an increased risk of cardiovascular 
disease due to the accelerated accumulation of 
atherosclerosis (1, 2). Despite abundant evidence 
for the role of diabetes in the pathophysiology of 
atherosclerosis and clinical cardiovascular events, 
insights into the contribution of early disruptions in 
serum levels of insulin and glucose on the development 
of atherosclerosis remain scarce. Moreover, levels of 
serum insulin and their atherogenic properties are even 
conflicting (3, 4, 5).
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Another important topic of interest within the field 
of atherosclerosis, for which the role of serum levels 
of insulin and glucose are even more elusive, pertains 
to plaque composition. Plaque composition is directly 
related to the chances of a plaque to rupture and 
potentially result in clinical cardiovascular events (6, 7, 9). 
The vulnerability of a plaque to rupture is assessed by 
evaluation of the presence of vulnerable, non-calcified 
plaque components such as lipid core or intraplaque 
hemorrhage (9) and the presence of calcification, which is 
regarded as a more plaque-stabilizing component (3, 4, 5). 
In-vivo visualization of the atherosclerotic plaque and 
its components can be non-invasively accomplished by 
MRI (10).
Against this background, we investigated the 
association between insulin and glucose levels with 
atherosclerotic plaque composition in the carotid artery 
in a large population-based cohort of subjects with 
subclinical atherosclerosis.
Methods
Study population
The Rotterdam Study is a prospective population-based 
cohort (11). Between 2007 and 2012, participants with 
carotid atherosclerosis were invited to undergo an MRI 
scan of the carotid arteries. Participants were selected 
for MRI based on the results of carotid artery ultrasound 
examination (intima-media thickness ≥2.5 mm in one or 
both carotid arteries) performed in all participants of the 
Rotterdam Study. From the 2666 invited participants, 272 
refused to participate and another 363 did not undergo 
an MRI scan due to claustrophobia (n = 57), physical 
limitations (n = 191), and MRI contraindication (n = 115). 
From the remaining 1982 participants that underwent 
MRI scan, 242 were excluded due to bad image quality 
(n = 95), the absence of plaque (n = 41), or incomplete 
examinations due to claustrophobia during scanning 
(n = 106). Hence, 1740 participants were included in 
the analyses (Fig. 1). The Rotterdam Study complies 
with the Helsinki Declaration and has been approved 
by the Medical Ethics Committee of the Erasmus MC 
and by the Dutch Ministry of Health, Welfare, and 
Sports, implementing the ‘Wet Bevolkings Onderzoek: 
ERGO (Population Screening Act: Rotterdam Study)’. 
All participants provided written informed consent to 
participate in the study and to obtain information from 
their treating physicians.
Carotid scanning and analysis of 
plaque components
A magnetic resonance 1.5 Tesla scanner (GE Healthcare) 
with a dedicated bilateral phased-array surface coil 
(Machnet, Eelde, the Netherlands) was used to perform 
bilateral multisequence imaging of the carotid arteries, 
with a standardized scanning protocol that required an 
approximate total scanning time of 30 min. Details of the 
scanning protocol, reading procedure, and reproducibility 
are described in detail elsewhere (12, 13). Two independent 
readers, with 3 years of experience visually evaluated the 
carotid artery images for the presence of three plaque 
components, namely intraplaque hemorrhage (IPH), lipid 
core, and calcification. IPH was defined as the presence 
of a hyperintense region in the atherosclerotic plaque 
on 3D-T1w-GRE. Lipid core presence was defined as a 
hypointense region, not classified as IPH or calcification, 
in the plaque on PDw-FSE or PDw-EPI and T2w-EPI images 
or a region of relative signal intensity drop in the T2w-EPI 
images compared with the PDw-EPI images. Calcification 
was defined as the presence of a hypointense region in 
the plaque on all sequences (14). Subjects were recorded 
as positive for the presence of any plaque component 
if the component was identified in one or both carotid 
arteries. To assess the intra-scan variability, 40 participants 
underwent a second MRI scan (average time between 
scans 15 ± 9 days). For interobserver reproducibility 
analyses, random MRI examinations were selected 
Figure 1
Flow chart of the participants included in the analysis.
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(n = 50) and read by a second observer. Intra-scan and 
interobserver agreement were calculated by using Cohens’ 
Kappa statistics. The intra-scan agreement was good for 
all measurements. The Kappa value for the presence 
of IPH was 0.95 (95% CI: 0.88–0.99), for lipid core 0.85 
(95% CI: 0.74–0.96), and for calcification 0.91 (95% CI: 
0.82–0.99). The interobserver agreement was good for all 
measurements. The Kappa value for IPH was 0.86 (95% CI: 
0.72–0.99), for lipid core 0.86 (95% CI: 0.72–0.99), and for 
calcification 0.94 (95% CI: 0.86–0.99) (13).
Assessment of fasting insulin and glucose levels
The venous blood samples were taken after overnight fasting 
from all participants at the research center and stored at 
−80°C in a number of 5-mL aliquots. Serum fasting glucose 
levels were determined by using the glucose hexokinase 
method within 1 week after sampling (15). Serum fasting 
insulin level was determined in samples that had been 
kept frozen and were measured on a Roche Modular 
Analytics E170 analyzer (Roche Diagnostics GmbH, 
Mannheim, Germany) by electrochemiluminescence 
immunoassay technology. This assay does not cross-react 
with proinsulin or C-peptide. The intraassay repeatability 
showed a coefficient of variation of 1.0%. The day-to-day 
variation of the assay (i.e. intermediate precision) yielded 
a coefficient of variation of 3.6%. These numbers indicate 
the excellent reliability of the insulin assay in our 
study (16). We used the following formula to calculate 
the HOMA–IR index (fasting insulin (mU/L) × fasting 
glucose (mmol/L))/22.5 (17). The blood measurements 
were made for all participants at study entry, and the 
mean time interval between blood measurements and 
carotid MRI scan was 7.9 years (s.d. of 4.0 years).
Other risk factors in the Rotterdam Study
The information about other cardiovascular risk factors as 
relevant covariables was obtained by interview, physical 
examination, and blood sampling between the years 
1998 and 2008 (11). Diabetes mellitus was defined as 
fasting blood glucose >6.9 mmol/L, nonfasting glucose 
>11.0 mmol/L, or use of glucose-lowering medication. 
Systolic and diastolic blood pressure was measured using 
a random-zero sphygmomanometer on the right arm 
and two measurements were averaged for the analysis. 
Smoking status was assessed by interview and categorized 
into never, past, and current smoking. BMI was calculated 
based on the weight in kilograms divided by height in 
meters squared. Waist circumference (WC) was measured 
at the midpoint between the lower rib and the iliac crest 
in all participants with standing position and gentle 
breathing. Total cholesterol and high-density lipoproteins 
(HDL) levels were measured using standard laboratory 
techniques. The information on the use of antihypertensive 
medication and lipid-lowering medication was obtained 
from pharmacy records (11). History of stroke or coronary 
heart disease (CHD) was self-reported at study entry and 
verified by clinical data from the medical records or the 
occurrence during study follow-up but before the time of 
carotid MRI scanning.
Statistical analysis
The distribution of continuous and categorical variables 
was described using means (s.d.), medians (interquartile 
ranges (IQRs)), or percentages. We performed a 
natural logarithmic transformation to normalize the 
distributions of serum insulin and glucose. To investigate 
the association between fasting insulin and glucose 
levels with intraplaque hemorrhage (IPH), lipid core, and 
calcification, a three-step statistical analysis approach 
was used. First, we investigated the association between 
fasting insulin and glucose levels with the presence 
of each component in one or both carotid arteries 
using logistic regression models. In model 1, adjusted 
for sex, age, intima-media thickness, and the time 
difference between insulin and glucose measurements 
and MRI scan. In model 2, additionally adjusted for 
smoking, serum high-density lipoprotein, serum total 
cholesterol, systolic and diastolic blood pressure, diabetes 
mellitus, BMI, waist circumference, use of anti-diabetic 
medication, use of antihypertensive medication, and 
insulin or glucose levels, dependent on the determinant 
under investigation. In model 3, additionally adjusted 
for the use of lipid-lowering medication (13), vitamin K 
antagonists and antiplatelet agents (18). Second, we 
categorized serum insulin and glucose levels into tertiles 
and investigated the association of tertiles of insulin and 
glucose (lowest tertile was used as the reference category) 
with carotid plaque components using regression model 1. 
Third, we performed the following three sensitivity 
analyses. In the first analysis, we investigated all the 
previously mentioned associations only in participants 
that had their MRI-scan and blood measurements within 
1 year in order to assess the potential effect of the time 
delay between the measurements. In the second analysis, 
we reassessed all associations in participants that were 
free of diabetes mellitus at the time of the MRI. In 
the third analysis, we stratified all analyses for sex, to 
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investigate whether associations are different between 
males and females. Additionally, we investigated the 
association between serum insulin and glucose and 
intima-media thickness and association between HOMA 
index and carotid composition using regression models. 
All analyses were carried out using IBM SPSS Statistical 
package version 21.
Results
Table 1 shows the population characteristics at the MRI 
scan. The mean age of the population was 72.9 years 
(9.1 years) and 46.0% were women. A total of 251 (14.4%) 
participants were diagnosed with diabetes mellitus at 
baseline. The median (IQR) fasting insulin level was 
74 (50–98) pmol/L and the median (IQR) fasting glucose 
level was 5.6 (5.2–6.0) mmol/L.
Associations between fasting insulin and glucose levels 
with the different plaque components are summarized in 
Table 2. We found that higher fasting insulin levels were 
associated with the presence of intraplaque hemorrhage 
(fully adjusted odds ratio (OR) per 1-s.d. increase in 
insulin level: 1.38 (95% CI: 1.09–1.74)) (Table 2, model 2). 
Further adjustment for antithrombotic treatment 
increased the estimate and empowered the association 
(OR per 1-s.d. increase: 1.42 (95% CI: 1.12–1.79)) (Table 2, 
model 3). No association was found with the presence of 
calcification or lipid core. Also, when assessing the glucose 
levels, we found no association between fasting glucose 
levels with any of the plaque components. Furthermore, 
no association was found between the HOMA index and 
carotid plaque components (Table 2).
When investigating tertiles of insulin and glucose 
levels, we found that the high insulin level tertile was 
associated with a higher frequency of intraplaque 
hemorrhage (adjusted OR of highest vs lowest tertile: 1.32 
(95% CI: 1.01–1.75)) and a lower frequency of lipid core 
(adjusted OR of highest vs lowest tertile: 0.69 (95% CI: 
0.54–0.88)) compared to the low tertile (Fig. 2). Again, for 
glucose, we did not find any association with the various 
plaque components (Fig. 3).
When restricting analyses only to participants 
who had both measurements (insulin and glucose 
Table 1 Baseline characteristics of the study population (n = 1740). Values are presented as mean ± s.d. and median 
(interquartile ranges) for continuous variables and percentages for dichotomous or categorical variables. P-values were derived 
by Fisher’s exact test or ANOVA.
Characteristics
Insulin 
P-value Total≤57 58–89 >90
Number in category 587 615 538 1740
Age, years (s.d.) 74.0 ± 8.8 73.4 ± 9.1 71.1 ± 9.4 <0.001 72.9 ± 9.1
Women, % 48.9 47.2 41.4 0.03 46.0
Smoking, current, % 43.3 41.1 42.9 0.41 42.4
Diabetes mellitus, % 8.2 11.4 24.7 <0.001 14.4
Fasting glucose, mmol/L (s.d.) 5.3 (5.0–5.7) 5.6 (5.2–5.9) 5.9 (5.4–6.5) <0.001 5.6 (5.2–6.0)
Fasting insulin, pmol/L 44 (35–51) 75 (66–85) 121 (100–165) <0.001 74 (50–98)
Homa index 2.3 (2.1–2.5) 2.9 (2.7–3.1) 3.4 (3.2–3.8) <0.001 2.9 (2.5–3.2) 
Systolic blood pressure, mm/Hg (s.d.) 144 ± 20 147 ± 20 144 ± 20 0.02 145 ± 20
Diastolic blood pressure, mm/Hg (s.d.) 79 ± 10 81 ± 10 81 ± 11 0.001 80 ± 10
BMI, kg/m2 (s.d.) 25.7 ± 3.0 27.1 ± 3.1 29.2 ± 3.7 <0.001 27 ± 3.5
Waist circumference, cm 89.7 ± 9.9 93.8 ± 10.0 99.9 ± 11.0 <0.001 94.3 ± 11.1
Total cholesterol, mmol/L (s.d.) 5.6 ± 1.0 5.7 ± 1.0 5.5 ± 1.0 0.004 5.6 ± 1.0
HDL cholesterol, mmol/L (s.d.) 1.5 ± 0.3 1.4 ± 0.3 1.2 ± 0.3 <0.001 1.4 ± 0.3
Antihypertensive medication, % 32.0 36.6 50.4 <0.001 39.3
Antidiabetic medication, % 6.3 8.3 19.0 <0.001 10.9
Statin use, % 25.6 28.6 33.3 0.02 29.0
Vitamin K antagonists, % 5.8 5.7 5.2 0.90 5.6
Antiplatelet agents, % 27.6 26.5 28.4 0.76 27.5
Intima-media thickness, mm 3.2 ± 0.6 3.2 ± 0.6 3.2 ± 0.7 0.77 3.2 ± 0.6
Degree of stenosis, (%) 12.3 (0.0–25.9) 14.5 (0.0–26.4) 15.2 (0.0–28.0) 0.16 14.5 (0.0–26.8)
History of stroke, % 4.6 7.2 6.5 0.02 6.3
History of coronary heart disease, % 12.8 10.1 11.5 0.01 11.4
Presence of calcification, % 85.7 80.2 81.0 0.02 82.3
Presence of lipid core, % 47.2 45.5 38.8 0.01 44.0
Presence of intraplaque hemorrhage, % 32.5 35.9 35.5 0.41 34.7
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measurements and MRI scan) within 6 months (n = 122) 
or less and within 1 year (n = 212), the results were in 
a similar trend (Supplementary Tables 1 and 2, see 
section on supplementary materials given at the end of 
this article). Similarly, the results did not change when 
we excluded participants with a diagnosis of diabetes 
mellitus at the time of MRI (n = 1489) (Supplementary 
Table 3). Furthermore, after stratifying the analyses 
by sex, similar effect estimates, between males and 
females, for the relation of serum insulin levels with 
IPH and lipid core were seen. Whereas no association 
was observed for calcification in both sexes. Also, when 
assessing the relationship between glucose and plaque 
components, no association was observed in either sex 
(Supplementary Table 4). Moreover, when assessing 
the relationship between serum insulin or glucose and 
carotid intima-media thickness, no association was 
found (Supplementary Table 5). No further stratified 
analyses were performed for the HOMA index.
Discussion
In this large population-based study of subjects with 
subclinical carotid atherosclerosis, we observed that 
higher fasting serum insulin levels were associated 
with the presence of intraplaque hemorrhage within 
the carotid atherosclerotic plaque. We did not find an 
association between fasting glucose levels and any of the 
carotid plaque components.
Until now, most of the evidence linking insulin and 
glucose to atherosclerosis comes from studies in which 
atherosclerotic cardiovascular clinical endpoints, such as 
ischemic heart disease or ischemic stroke, were investigated 
(19, 20, 21). Hyperinsulinemia was found to increase 
the risk of ischemic heart disease among 4637 middle-
aged men from the Quebec Cardiovascular Study (19) 
and the risk of acute coronary and cerebrovascular 
Table 2 Association serum insulin, glucose and HOMA index 
with carotid artery plaque composition (n = 1740) and glucose 
(per s.d. increment) with intraplaque hemorrhage (IPH), lipid 
core and calcification. Data are presented as OR (95% CI).
IPH Lipid core Calcification
Insulin
 Model 
1
1.27 (1.05–1.55) 0.76 (0.63–0.90) 0.93 (0.74–1.16)
 Model 
2*
1.38 (1.09–1.74) 0.89 (0.72–1.10) 1.06 (0.80–1.39)
 Model 
3
1.42 (1.12–1.79) 0.90 (0.73–1.11) 1.05 (0.79–1.39)
Glucose
 Model 
1
1.04 (0.55–1.96) 0.51 (0.29–0.91) 1.19 (0.58–2.47)
 Model 
2†
0.47 (0.18–1.19) 1.09 (0.48–2.46) 0.90 (0.31–2.58)
 Model 
3
0.45 (0.18–1.16) 1.10 (0.49–2.49) 0.90 (0.31–2.57)
HOMA index
 Model 
1
1.65 (1.01–2.71) 0.49 (0.32–0.77) 0.80 (0.45–1.44)
 Model 
2*†
0.37 (0.03–4.51) 1.33 (0.13–13.8) 0.05 (0.01–1.85)
 Model 
3
0.39 (0.03–4.74) 1.36 (0.13–14.1) 0.05 (0.01–2.01)
Data are presented as OR (95% CI). Model 1 = adjusted for sex, age, 
intima-media thickness, and the time difference between insulin and 
glucose measurements and MRI scan. Model 2 = model 1 + smoking, 
high-density lipoprotein, total cholesterol, systolic and diastolic blood 
pressure, diabetes mellitus, BMI, waist circumference, use of anti-diabetic 
medication, use of antihypertensive medication, and *glucose or †insulin 
levels. Model 3 = model 2 + use of lipid-lowering medication, vitamin K 
antagonists, and antiplatelet agents.
Figure 2
Association of serum insulin levels (tertiles) with plaque 
composition in the carotid artery. Values on the x-axis 
represent the odds ratios and 95% confidence interval. The 
values are adjusted for sex, age, and intima-media thickness. 
Statistics was performed using logistic regression using total 
sample of subjects n = 1740. P-trend over categories of insulin 
for intraplaque hemorrhage was 0.04, for lipid core was 0.003, 
and for calcification was 0.32.
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events in 1521 men enrolled in Kuopio Ischemic Heart 
Disease Risk Factor Study (20). Our results extend on 
these findings by showing that preclinical changes 
in serum insulin levels relate to a more vulnerable 
composition of the carotid atherosclerotic plaque. More 
specifically, we demonstrated that high serum insulin 
levels, especially related to the presence of intraplaque 
hemorrhage, the plaque component which is regarded 
as the most vulnerable (22). Similarly, insulin was found 
to increase intraretinal hemorrhage and extraretinal 
neovascularization in rats (23). Previous animal studies 
described insulin to play a pleiotropic effect on the 
vascular system, through vascular endothelial growth 
factor (VEGF), which plays a pivotal role in angiogenesis 
(23, 24). High levels of insulin increase the levels of VEGF, 
which in turn induce abnormal neovascularization that is 
prone to leakage and hemorrhage (23).
In contrast to high or low serum insulin levels, it may be 
speculated that physiological concentration levels (median 
levels 66–85 pmol/L) potentially behave protectively against 
atherosclerosis. Observations in our study showed that 
medium levels of serum insulin were not associated with 
any vulnerable plaque component, but were associated with 
a lower presence of calcification, which may support the 
hypothesis that medium levels of serum insulin have the 
protective effect (Fig. 2). In the same line, a recent animal 
study that examined the role of insulin in atherosclerotic 
plaque reported the protective effect of insulin on 
atherosclerosis (22). In this study, the insulin effect was 
tested on atherosclerosis in a mouse model, and insulin was 
found to decrease the plaque burden and increased plaque 
stability via nitric oxide synthase (NOS) mechanisms (22). 
Furthermore, it was found that insulin reduced macrophage 
accumulation and plaque necrosis and increased 
collagen and smooth muscle cell accumulation (22). 
However, it seems that only disrupted levels of serum 
insulin, low and high insulin levels, link serum insulin with 
atherosclerosis. Previously, animal studies demonstrated 
also that impaired insulin signaling by genetic modification 
accelerated atherosclerosis (25, 26, 27).
Surprisingly, we found no effects of serum glucose 
levels in carotid plaque composition. In the context of 
glucose, our findings are in contrast with studies that link 
glucose levels below 7.0 mmol/L with an increased risk of 
vascular disease (28). However, a recent meta-analysis of 
102 prospective studies that investigated the relationship 
between fasting glucose levels and risk of vascular diseases 
concluded that glucose concentrations were non-linear 
and modestly associated with the risk of vascular diseases 
among individuals without diabetes (21), meaning that 
glucose levels below and higher than 7.0 mmol/L were 
associated with increased risk for coronary heart disease 
and ischemic stroke (21).
In terms of clinical practice, our findings may have 
clinical implications given that these suggest that fasting 
serum insulin conveys information on the atherosclerotic 
plaque composition that may ultimately be used for risk 
stratification of patients in daily practice.
The major strength of our study includes the largest 
population-based sample of individuals with subclinical 
carotid atherosclerosis and the MRI-based assessment 
carotid plaque composition. Given the accurate diabetes 
assessments within the Rotterdam Study, we were able to 
address, for the first time, the association between subclinical 
variations of insulin and glucose levels with atherosclerotic 
disease. Nevertheless, our study should be interpreted in the 
context of some limitations. First, the cross-sectional study 
Figure 3
Association of serum glucose levels (tertiles) with plaque 
composition in the carotid artery. Values on the x-axis 
represent the odds ratios and 95% confidence interval. The 
values are adjusted for sex, age, and intima-media thickness. 
Statistics was performed using logistic regression using total 
sample of subjects n = 1740. P-trend over categories of glucose 
for intraplaque hemorrhage was 0.87, for lipid core was 0.33, 
and for calcification was 0.81.
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design limits us to draw causal inferences between fasting 
insulin and atherosclerotic plaque components. Second, 
in a substantial part of our study population, the time 
interval between insulin and glucose measurements and 
MRI scanning was more than 2 years. However, limiting 
our analyses to the subgroup of participants with available 
measurements of MRI and serum insulin levels in the same 
year did show different associations.
Conclusion
In conclusion, serum insulin levels are associated with 
the presence of vulnerable components of carotid plaque, 
specifically with intraplaque hemorrhage, suggesting 
that serum insulin may play a role in the vulnerability of 
carotid atherosclerotic plaque. Further studies are required 
to confirm our findings in a longitudinal design.
Supplementary materials
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